Jun 4, 2024, 08:23
James Hadfield: Looking forward to speaking at FOGBoston
James Hadfield, Director of Epigenomics Oncology Translational Medicine at AstraZeneca, posted on X:
“Looking forward to speaking at FOGBoston and joining a panel discussion about ctDNA screening. Get your free ticket and say hi here. I’ll be talking about ‘ctDNA and a pathway to cure’ so if you are working in ctDNA, MRD or EDx please connect.”
Source: James Hadfield/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59